Rosiglitazone and Outcomes for Patients with Diabetes and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

BACKGROUND: Rosiglitazone improves glycemic control for patients with type 2 diabetes, but there remains controversy regarding an observed association with cardiovascular hazard. The cardiovascular effects of rosiglitazone for patients with coronary artery disease (CAD) remain unknown. METHODS AND R...

Full description

Saved in:
Bibliographic Details
Main Authors: Bach, Richard G., Brooks, Maria Mori, Lombardero, Manuel, Genuth, Saul, Donner, Thomas W., Garber, Alan, Kennedy, Laurence, Monrad, E. Scott, Pop-Busui, Rodica, Kelsey, Sheryl F., Frye, Robert L.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816149/
https://ncbi.nlm.nih.gov/pubmed/23857320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.112.000678
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items